Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update Globe Newswire · Nov 4, 2026
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS Cision · Nov 4, 2026
Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences Cision · Nov 4, 2026
IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations Events Cision · Nov 4, 2026
InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day Globe Newswire · Nov 3, 2026
Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients Globe Newswire · Nov 3, 2026
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery Cision · Nov 3, 2026
IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update Cision · Nov 3, 2026
